Literature DB >> 23020974

The anterograde transport of the human neuropeptide Y2 receptor is regulated by a subtype specific mechanism mediated by the C-terminus.

Cornelia Walther1, Jonathan Lotze, Annette G Beck-Sickinger, Karin Mörl.   

Abstract

The export of newly synthesized proteins, including G protein-coupled receptors (GPCR), from the endoplasmic reticulum (ER) and further transport to the plasma membrane is a tightly regulated process. ER export and subsequent cell surface targeting of GPCR is initially mediated through COPII-coated vesicles. It is governed by specific amino acid sequences located in extracellular as well as intracellular receptor domains, for example in the C-terminus (CT) of the receptor. Herein, we determined the role of the CT in the anterograde transport of the human neuropeptide Y receptor (hYR) type 2. We identified a short sequence motif in the membrane proximal CT: Y(x)(3)F(x)(3)F in the region of the putative 8th helix has a critical functional relevance for the anterograde transport of hY(2)R, since its deletion leads to accumulation of the receptor in the ER. It is sequence and position specific. Furthermore we identified a distinct role of C-terminal sequences in hY(1)R, hY(2)R, hY(4)R and hY(5)R. Regulation of hY(5)R export is regulated by a different mechanism as compared to hY(2)R. Different sequence elements with respect to function and localization are involved as demonstrated by the construction of a hY(2)/hY(5) receptor chimera and a noneffective deletion in the region of helix eight in the hY(5)R. In contrast to hY(2)R, deletion of the corresponding helical segment F(x)(3)L(x)(3)F has no influence on anterograde transport of hY(1)R, whereas deletion of F(x)(3)I(x)(3)V in hY(4)R restrains the receptor to the Golgi apparatus. Interestingly this pattern is not mirrored by repression of COPII vesicle transport by Sar1[H79G] overexpression. Whereas the 8th helix is involved before or at the level of Sar1 dependent export pathways in the ER for the hY(2)R, in hY(4)R helix eight is involved at later stages of anterograde transport.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23020974     DOI: 10.1016/j.npep.2012.08.011

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  7 in total

1.  Mutations in arrestin-3 differentially affect binding to neuropeptide Y receptor subtypes.

Authors:  Luis E Gimenez; Stefanie Babilon; Lizzy Wanka; Annette G Beck-Sickinger; Vsevolod V Gurevich
Journal:  Cell Signal       Date:  2014-03-29       Impact factor: 4.315

2.  C-terminal motif of human neuropeptide Y4 receptor determines internalization and arrestin recruitment.

Authors:  Lizzy Wanka; Stefanie Babilon; Kerstin Burkert; Karin Mörl; Vsevolod V Gurevich; Annette G Beck-Sickinger
Journal:  Cell Signal       Date:  2016-11-03       Impact factor: 4.315

Review 3.  Mechanisms of the anterograde trafficking of GPCRs: Regulation of AT1R transport by interacting proteins and motifs.

Authors:  Maoxiang Zhang; Guangyu Wu
Journal:  Traffic       Date:  2018-12-07       Impact factor: 6.215

Review 4.  Regulation of α2B-Adrenerigc Receptor Export Trafficking by Specific Motifs.

Authors:  Guangyu Wu; Jason E Davis; Maoxiang Zhang
Journal:  Prog Mol Biol Transl Sci       Date:  2015-03-31       Impact factor: 3.622

Review 5.  NPY and Gene Therapy for Epilepsy: How, When,... and Y.

Authors:  Stefano Cattaneo; Gianluca Verlengia; Pietro Marino; Michele Simonato; Barbara Bettegazzi
Journal:  Front Mol Neurosci       Date:  2021-01-22       Impact factor: 5.639

6.  Specific motifs mediate post-synaptic and surface transport of G protein-coupled receptors.

Authors:  Xin Xu; Zhe Wei; Guangyu Wu
Journal:  iScience       Date:  2021-12-18

7.  Improved in Vitro Folding of the Y2 G Protein-Coupled Receptor into Bicelles.

Authors:  Peter Schmidt; Brian J Bender; Anette Kaiser; Khushboo Gulati; Holger A Scheidt; Heidi E Hamm; Jens Meiler; Annette G Beck-Sickinger; Daniel Huster
Journal:  Front Mol Biosci       Date:  2018-01-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.